I 
114TH CONGRESS 
1ST SESSION 
H. R. 953 
To authorize the Attorney General to award grants to address the national 
epidemics of prescription opioid abuse and heroin use. 
IN THE HOUSE OF REPRESENTATIVES 
FEBRUARY 12, 2015 
Mr. SENSENBRENNER (for himself, Mr. RYAN of Ohio, Ms. DUCKWORTH, Mr. 
CHABOT, Mr. MARINO, Mr. SCOTT of Virginia, and Mr. JOYCE) intro-
duced the following bill; which was referred to the Committee on the Ju-
diciary, and in addition to the Committees on Energy and Commerce and 
Education and the Workforce, for a period to be subsequently determined 
by the Speaker, in each case for consideration of such provisions as fall 
within the jurisdiction of the committee concerned 
A BILL 
To authorize the Attorney General to award grants to ad-
dress the national epidemics of prescription opioid abuse 
and heroin use. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 
(a) SHORT TITLE.—This Act may be cited as the 
‘‘Comprehensive Addiction and Recovery Act of 2015’’. 
(b) TABLE OF CONTENTS.—The table of contents for 
this Act is as follows: 
VerDate Sep 11 2014 
03:28 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
Sec. 1. Short title; table of contents. 
Sec. 2. Findings. 
Sec. 3. Definitions. 
TITLE I—PREVENTION AND EDUCATION 
Sec. 101. Development of best prescribing practices. 
Sec. 102. National education campaign. 
Sec. 103. Community-based coalition enhancement grants to address local drug 
crises. 
TITLE II—LAW ENFORCEMENT AND TREATMENT 
Sec. 201. Treatment alternative to incarceration programs. 
Sec. 202. Law enforcement naloxone training and implementation demonstra-
tion. 
Sec. 203. Prescription drug take back expansion. 
TITLE III—TREATMENT AND RECOVERY 
Sec. 301. Evidence-based opioid and heroin treatment and interventions dem-
onstration. 
Sec. 302. Criminal justice medication assisted treatment and interventions dem-
onstration. 
Sec. 303. National youth recovery initiative. 
Sec. 304. Building communities of recovery. 
TITLE IV—ADDRESSING COLLATERAL CONSEQUENCES 
Sec. 401. Correctional education demonstration grant program. 
Sec. 402. Revision of FAFSA form. 
Sec. 403. National Task Force on Recovery and Collateral Consequences. 
TITLE V—ADDICTION AND TREATMENT SERVICES FOR WOMEN, 
FAMILIES, AND VETERANS 
Sec. 501. Authority to award competitive grants to address opioid and heroin 
abuse by pregnant and parenting female offenders. 
Sec. 502. Grants for family-based substance abuse treatment. 
Sec. 503. Veterans’ treatment courts. 
TITLE VI—INCENTIVIZING STATE COMPREHENSIVE INITIATIVES 
TO ADDRESS OPIOID AND HEROIN ABUSE 
Sec. 601. State demonstration grants for comprehensive opioid abuse response. 
TITLE VII—OFFSET; GAO REPORT 
Sec. 701. Offset. 
Sec. 702. GAO report on IMD exclusion. 
SEC. 2. FINDINGS. 
Congress finds the following: 
(1) The abuse of heroin and prescription pain-
killers is having a devastating effect on public health 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
and safety in communities across the United States. 
According to the Centers for Disease Control and 
Prevention, drug overdose deaths now surpass traffic 
crashes in the number of deaths caused by injury in 
the United States. In 2011, an average of about 110 
people in the United States died from drug overdose 
every day. 
(2) Law enforcement officials and treatment ex-
perts throughout the country report that many pre-
scription opioid users have turned to heroin as a 
cheaper or more easily obtained alternative to pre-
scription drugs. 
(3) Opioid pain relievers are the most widely 
misused or abused controlled prescription drugs 
(commonly referred to as ‘‘CPDs’’) and are involved 
in most CPD-related overdose incidents. According 
to the Drug Abuse Warning Network (commonly 
known as ‘‘DAWN’’), the estimated number of emer-
gency department visits involving nonmedical use of 
prescription opiates or opioids increased by 112 per-
cent between 2006 and 2010, from 84,671 to 
179,787. 
(4) According to a report by the National Asso-
ciation of State Alcohol and Drug Abuse Directors 
(commonly referred to as ‘‘NASADAD’’), 37 States 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
reported an increase in admissions to treatment for 
heroin use during the past 2 years, while admissions 
to treatment for prescription opiates increased 500 
percent from 2000 to 2012. 
(5) Substance use disorders are a treatable dis-
ease. Discoveries in the science of addiction have led 
to advances in the treatment of substance use dis-
orders that help people stop abusing drugs and pre-
scription medications and resume their productive 
lives. 
(6) According to the National Survey on Drug 
Use and Health, approximately 22,700,000 people in 
the United States needed substance use disorder 
treatment in 2013, but only 2,500,000 people re-
ceived it. Furthermore, current treatment services 
are not adequate to meet demand. According to a re-
port commissioned by SAMHSA, there are approxi-
mately 32 providers for every 1,000 individuals 
needing substance use disorder treatment. In some 
States, the ratio is much lower. 
(7) Effective substance abuse prevention can 
yield major economic dividends. 
(8) According to the National Institute on Drug 
Abuse, when schools and communities properly im-
plement science-validated substance abuse prevention 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
programs, abuse of alcohol, tobacco, and illicit drugs 
is reduced. Such programs help teachers, parents, 
and healthcare professionals shape the perceptions 
of youths about the risks of drug abuse. 
(9) Diverting individuals with substance use 
disorders from criminal justice systems into commu-
nity-based treatment can save billions of dollars and 
prevent sizeable numbers of crimes, arrests, and re- 
incarcerations over the course of those individuals’ 
lives. 
(10) According to the Drug Enforcement Agen-
cy, more than 1,700 tons of expired, unwanted pre-
scription medications have been collected during the 
past 31⁄2 years, following the enactment of the Se-
cure and Responsible Drug Disposal Act of 2010 
(Public Law 111–273; 124 Stat. 2858). 
(11) Research shows that combining treatment 
medications with behavioral therapy is the best way 
to facilitate success for most patients. Treatment ap-
proaches must be tailored to address the drug abuse 
patterns and drug-related medical, psychiatric, and 
social problems of each individual. Different types of 
medications may be useful at different stages of 
treatment or recovery to help a patient stop using 
drugs, stay in treatment, and avoid relapse. 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
(12) Research indicates that combating the 
opioid crisis, including abuse of prescription pain-
killers and, increasingly, heroin, requires a multi- 
pronged approach that involves reducing drug diver-
sion, expanding delivery of existing treatments (in-
cluding medication assisted treatments), expanding 
access to overdose medications and interventions, 
and the development of new medications for pain 
that can augment the existing treatment arsenal. 
(13) Individuals with mental illness, especially 
severe mental illness, are at considerably higher risk 
for substance abuse than the general population, and 
the presence of a mental illness complicates recovery 
from substance abuse. 
SEC. 3. DEFINITIONS. 
In this Act— 
(1) the term ‘‘medication assisted treatment’’ 
means the use, for problems relating to heroin and 
other opioids, of medications approved by the Food 
and Drug Administration in combination with coun-
seling and behavioral therapies; 
(2) the term ‘‘ONDCP Recovery Branch’’ 
means the Recovery Branch of the Office of Na-
tional Drug Control Policy; 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
(3) the term ‘‘opioid’’ means any drug having 
an addiction-forming or addiction-sustaining liability 
similar to morphine or being capable of conversion 
into a drug having such addiction-forming or addic-
tion-sustaining liability; and 
(4) the term ‘‘State’’ means any State of the 
United States, the District of Columbia, the Com-
monwealth of Puerto Rico, and any territory or pos-
session of the United States. 
TITLE I—PREVENTION AND 
EDUCATION 
SEC. 101. DEVELOPMENT OF BEST PRESCRIBING PRAC-
TICES. 
(a) INTER-AGENCY TASK FORCE.—Not later than 
120 days after the date of enactment of this Act, the Sec-
retary of Health and Human Services (referred to in this 
section as the ‘‘Secretary’’), in cooperation with the Sec-
retary of Veterans Affairs, the Secretary of Defense, and 
the Administrator of the Drug Enforcement Administra-
tion, shall convene a Pain Management Best Practices 
Inter-Agency Task Force (referred to in this section as 
the ‘‘task force’’). 
(b) MEMBERSHIP.—The task force shall be com-
prised of— 
(1) representatives of— 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
(A) the Department of Health and Human 
Services; 
(B) the Department of Veterans Affairs; 
(C) the Department of Defense; 
(D) the Drug Enforcement Administration; 
(E) the Centers for Disease Control and 
Prevention; 
(F) the Institute of Medicine; and 
(G) the Office of National Drug Control 
Policy; 
(2) the Director of the National Institutes of 
Health; 
(3) physicians, dentists, and non-physician pre-
scribers; 
(4) pharmacists; 
(5) experts in the fields of pain research and 
addiction research; 
(6) representatives of— 
(A) pain management professional organi-
zations; 
(B) the mental health treatment commu-
nity; 
(C) the addiction treatment community; 
(D) pain advocacy groups; and 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
(E) groups with expertise around overdose 
reversal; and 
(7) other stakeholders, as the Secretary deter-
mines appropriate. 
(c) DUTIES.—The task force shall— 
(1) not later than 180 days after the date on 
which the task force is convened under subsection 
(a), develop best practices for pain management (in-
cluding chronic and acute pain) and prescribing pain 
medication, taking into consideration— 
(A) existing pain management research; 
(B) recommendations from relevant con-
ferences; 
(C) ongoing efforts at the State and local 
levels and by medical professional organizations 
to develop improved pain management strate-
gies; and 
(D) the management of high-risk popu-
lations, other than populations who suffer pain, 
who— 
(i) 
may 
use 
or 
be 
prescribed 
benzodiazepines, 
alcohol, 
and 
diverted 
opioids; or 
(ii) receive opioids in the course of 
medical care; 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
(2) solicit and take into consideration public 
comment on the practices developed under para-
graph (1), amending such best practices if appro-
priate; and 
(3) develop a strategy for disseminating infor-
mation about the best practices developed under 
paragraphs (1) and (2) to prescribers, health profes-
sionals, pharmacists, State medical boards, and 
other parties, as the Secretary determines appro-
priate. 
(d) LIMITATION.—The task force shall not have rule-
making authority. 
(e) REPORT.—Not later than 270 days after the date 
on which the task force is convened under subsection (a), 
the task force shall submit to Congress a report that in-
cludes— 
(1) the strategy for disseminating best practices 
developed under subsection (c); 
(2) the results of a feasibility study on linking 
best practices developed under subsection (c) to re-
ceiving and renewing registrations under section 
303(f) of the Controlled Substances Act (21 U.S.C. 
823(f)); and 
(3) recommendations on how to apply best 
practices developed under subsection (c) to improve 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
prescribing practices at medical facilities, including 
medical facilities of the Veterans Health Administra-
tion. 
SEC. 102. NATIONAL EDUCATION CAMPAIGN. 
Title I of the Omnibus Crime Control and Safe 
Streets Act of 1968 (42 U.S.C. 3711 et seq.) is amended 
by adding at the end the following: 
‘‘PART MM—DRUG TREATMENT GRANTS 
‘‘SEC. 3031. DEFINITIONS. 
‘‘In this part— 
‘‘(1) the term ‘civil liability protection law’ 
means a State law that protects from civil liability 
individuals who give aid on a voluntary basis in an 
emergency to individuals who are ill, in peril, or oth-
erwise incapacitated; 
‘‘(2) the term ‘medication assisted treatment’ 
means the use, for problems relating to heroin and 
other opioids, of medications approved by the Food 
and Drug Administration in combination with coun-
seling and behavioral therapies; 
‘‘(3) the term ‘opioid’ means any drug having 
an addiction-forming or addiction-sustaining liability 
similar to morphine or being capable of conversion 
into a drug having such addiction-forming or addic-
tion-sustaining liability; and 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
‘‘(4) the term ‘Single State Authority for Sub-
stance Abuse’ has the meaning given the term in 
section 201(e) of the Second Chance Act of 2007 
(42 U.S.C. 17521(e)). 
‘‘SEC. 3032. NATIONAL EDUCATION CAMPAIGN. 
‘‘(a) DEFINITIONS.—In this section— 
‘‘(1) the term ‘eligible entity’ means a State, 
unit of local government, or nonprofit organization; 
and 
‘‘(2) the terms ‘elementary school’ and ‘sec-
ondary school’ have the meaning given those terms 
in section 9101 of the Elementary and Secondary 
Education Act of 1965 (20 U.S.C. 7801). 
‘‘(b) PROGRAM AUTHORIZED.—The Attorney Gen-
eral, in coordination with the Secretary of Health and 
Human Services, the Director of the Office of National 
Drug Control Policy, the Secretary of Education, the Ad-
ministrator of the Substance Abuse and Mental Health 
Services Administration, and the Director of the Centers 
for Disease Control and Prevention, may make grants to 
eligible entities to expand educational efforts to prevent 
abuse of opioids, heroin, and other substances of abuse, 
understand addiction as a chronic disease, and promote 
treatment and recovery, including— 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
‘‘(1) parent and caretaker-focused prevention 
efforts, including— 
‘‘(A) the development of research-based 
community education online and social media 
materials with an accompanying toolkit that 
can be disseminated to communities to educate 
parents and other caretakers of teens on— 
‘‘(i) how to educate teens about opioid 
and heroin abuse; 
‘‘(ii) how to intervene if a parent 
thinks or knows their teen is abusing 
opioids or heroin; 
‘‘(iii) signs of opioid or heroin over-
dose; and 
‘‘(iv) the use of naloxone to prevent 
death from opioid or heroin overdose; 
‘‘(B) the development of detailed digital 
and print educational materials to accompany 
the online and social media materials and tool-
kit described in subparagraph (A); 
‘‘(C) the development and dissemination of 
public service announcements to— 
‘‘(i) raise awareness of heroin and 
opioid abuse among parents and other 
caretakers; 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
‘‘(ii) motivate parents and other care-
takers to visit online educational materials 
on heroin and opioid abuse; and 
‘‘(iii) provide information for public 
health agencies and nonprofit organiza-
tions that provide overdose reversal and 
prevention services and community refer-
rals; and 
‘‘(D) the dissemination of educational ma-
terials to the media through— 
‘‘(i) a town hall or panel discussion 
with experts; 
‘‘(ii) a press release; 
‘‘(iii) an online news release; 
‘‘(iv) a media tour; and 
‘‘(v) sharable infographics; 
‘‘(2) prevention efforts focused on teenagers, 
young adults, and college students, including the de-
velopment of— 
‘‘(A) a national digital campaign; 
‘‘(B) a community education toolkit for use 
by community coalitions; 
‘‘(C) evidence-based resources for preven-
tion and treatment professionals targeting indi-
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
viduals who are between 18 and 24 years of 
age, including college students; and 
‘‘(D) technical support centers for preven-
tion and treatment professionals, elementary 
and secondary school-based professionals, and 
college-based professionals, including recovery 
staff, to implement and sustain evidence-based 
educational and prevention programs; 
‘‘(3) campaigns to inform individuals about 
available resources to aid in recovery from substance 
use disorder; 
‘‘(4) encouragement of individuals in or seeking 
recovery from substance use disorder to enter the 
health care system; or 
‘‘(5) adult-focused awareness efforts, including 
efforts focused on older adults, relating to prescrip-
tion medication disposal, opioid and heroin abuse, 
signs of overdose, and the use of naloxone for rever-
sal. 
‘‘(c) APPLICATION.— 
‘‘(1) IN GENERAL.—An eligible entity desiring a 
grant under this section shall submit an application 
to the Attorney General— 
‘‘(A) that meets the criteria under para-
graph (2); and 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00015
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
‘‘(B) at such time, in such manner, and 
accompanied by such information as the Attor-
ney General may require. 
‘‘(2) CRITERIA.—An eligible entity, in submit-
ting an application under paragraph (1), shall— 
‘‘(A) describe the evidence-based method-
ology and outcome measurements that will be 
used to evaluate the program funded with a 
grant under this section; 
‘‘(B) specifically explain how the measure-
ments described in subparagraph (A) will pro-
vide valid measures of the impact of the pro-
gram described in subparagraph (A); 
‘‘(C) describe how the program described 
in subparagraph (A) could be broadly replicated 
if demonstrated to be effective; 
‘‘(D) demonstrate that all planned services 
will be research-informed, which may include 
evidence-based practices documented in— 
‘‘(i) the report of the Institute of 
Medicine 
entitled 
‘Preventing 
Mental, 
Emotional, 
and 
Behavioral 
Disorders 
Among Young People’; or 
‘‘(ii) the National Registry of Effec-
tive Programs and Practices (commonly re-
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
ferred to as ‘NREPP’) of the Substance 
Abuse and Mental Health Administration; 
and 
‘‘(E) demonstrate that the eligible entity 
will effectively integrate and sustain the pro-
gram described in subparagraph (A) into cur-
riculum or community outreach efforts. 
‘‘(d) USE OF FUNDS.—A grantee shall use a grant 
received under this section for expenses of educational ef-
forts to— 
‘‘(1) prevent abuse of opioids, heroin, alcohol, 
and other drugs; or 
‘‘(2) promote treatment and recovery. 
‘‘(e) DURATION.—The Attorney General shall award 
grants under this section for a period not to exceed 2 
years. 
‘‘(f) PRIORITY CONSIDERATION WITH RESPECT TO 
STATES.—In awarding grants to States under this sec-
tion, the Attorney General shall give priority to a State 
that provides civil liability protection for first responders, 
health professionals, and family members administering 
naloxone to counteract opioid overdoses by— 
‘‘(1) enacting legislation that provides such civil 
liability protection; or 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
‘‘(2) providing a certification by the attorney 
general of the State that the attorney general has— 
‘‘(A) reviewed any applicable civil liability 
protection law to determine the applicability of 
the law with respect to first responders, health 
care professionals, family members, and other 
individuals who may administer naloxone to in-
dividuals reasonably believed to be suffering 
from opioid overdose; and 
‘‘(B) concluded that the law described in 
subparagraph (A) provides adequate civil liabil-
ity protection applicable to such persons. 
‘‘(g) INFORMATION SHARING.—The Office of the At-
torney General, in coordination with the Substance Abuse 
and Mental Health Services Administration and the De-
partment of Education, shall review existing evidence- 
based programs and emerging practices and programs and 
provide information to schools and communities about 
such programs and practices. 
‘‘(h) AUTHORIZATION OF APPROPRIATIONS.—There 
are authorized to be appropriated to carry out this section 
$2,500,000 for each of fiscal years 2016 through 2020.’’. 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
SEC. 103. COMMUNITY-BASED COALITION ENHANCEMENT 
GRANTS TO ADDRESS LOCAL DRUG CRISES. 
Part MM of title I of the Omnibus Crime Control 
and Safe Streets Act of 1968, as added by section 102, 
is amended by adding at the end the following: 
‘‘SEC. 3033. COMMUNITY-BASED COALITION ENHANCEMENT 
GRANTS TO ADDRESS LOCAL DRUG CRISES. 
‘‘(a) DEFINITIONS.—In this section— 
‘‘(1) the term ‘Drug-Free Communities Act of 
1997’ means chapter 2 of the National Narcotics 
Leadership Act of 1988 (21 U.S.C. 1521 et seq.); 
‘‘(2) the term ‘eligible entity’ means an organi-
zation that— 
‘‘(A) on or before the date of submitting 
an application for a grant under this section, 
receives or has received a grant under the 
Drug-Free Communities Act of 1997; and 
‘‘(B) has documented, using local data, 
rates of abuse of opioids at levels that are— 
‘‘(i) significantly higher than the na-
tional average as determined by the Attor-
ney General (including appropriate consid-
eration of the Monitoring the Future Sur-
vey published by the National Institute on 
Drug Abuse and the National Survey on 
Drug Use and Health by the Substance 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
Abuse and Mental Health Service Adminis-
tration); or 
‘‘(ii) higher than the national average, 
as determined by the Attorney General (in-
cluding appropriate consideration of the 
surveys described in clause (i)), over a sus-
tained period of time; and 
‘‘(3) the term ‘local drug crisis’ means, with re-
spect to the area served by an eligible entity— 
‘‘(A) a sudden increase in the abuse of 
opioids, as documented by local data; or 
‘‘(B) the abuse of prescription medications, 
specifically opioids, that is significantly higher 
than the national average, over a sustained pe-
riod of time, as documented by local data. 
‘‘(b) PROGRAM AUTHORIZED.—The Attorney Gen-
eral, in coordination with the Director, may make grants 
to eligible entities to implement comprehensive commu-
nity-wide strategies that address local drug crises within 
the area served by the eligible entity. 
‘‘(c) APPLICATION.— 
‘‘(1) IN GENERAL.—An eligible entity desiring a 
grant under this section shall submit an application 
to the Attorney General at such time, in such man-
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00020
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS
ule II, III, or IV controlled substance an 
informational report that shows how the 
prescribing patterns of the prescriber com-
pare to prescribing practices of the peers 
of the prescriber and expected norms; 
‘‘(iv) if informational reports provided 
to a prescriber under clause (iii) indicate 
that the prescriber is repeatedly falling 
outside of expected norms or standard 
practices for the prescriber’s field, direct 
the prescriber to educational resources on 
appropriate prescribing of controlled sub-
stances; 
‘‘(v) ensure that the prescriber licens-
ing board of the State receives a report de-
scribing any prescribers that repeatedly 
fall outside of expected norms or standard 
practices for the prescriber’s field, as de-
scribed in clause (iii); 
‘‘(vi) require consultation with the 
Single State Authority for Substance 
Abuse; and 
‘‘(vii) establish requirements for how 
data will be collected and analyzed to de-
termine the effectiveness of the program. 
VerDate Sep 11 2014 
02:36 Feb 25, 2015
Jkt 049200
PO 00000
Frm 00080
Fmt 6652
Sfmt 6201
E:\BILLS\H953.IH
H953
emcdonald on DSK67QTVN1PROD with BILLS